We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Brugada Sendromlu Hastada Sugammadeks Kullanımı.
- Authors
Biricik, Ebru; Hatipoğlu, Zehra; Küçükbingöz, Çağatay
- Abstract
Brugada Syndrome was first described in1992 by Pedro Brugada as a genetic syndrome that is characterized by ventricular arrhythmias that may result in sudden cardiac arrest. In particular, a right bundle branch block and ST segment elevation in the right precordial leads are observed. Many perioperative pharmalogical and physiological factors can trigger malignant arrhythmias. Although it is a rare condition, the anaesthestic management of Brugada syndrome is important because of the potentially fatal complications. Many anaesthetics have been administered during the operation of patients with Brugada Syndrome. The use of sugammadex instead of the anaesthetic management of patients with Brugada syndrome is discussed in this study.
- Publication
Turkish Journal of Anesthesia & Reanimation, 2016, Vol 44, Issue 2, p99
- ISSN
1304-0871
- Publication type
Article
- DOI
10.5152/TJAR.2016.60973